Workflow
Electrophysiology Devices
icon
Search documents
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 9, 2026 in Integer Holdings Corporation Lawsuit – ITGR
Globenewswire· 2026-01-15 00:00
Core Viewpoint - Integer Holdings Corporation (NYSE: ITGR) is facing allegations of issuing materially false and misleading statements regarding its competitive position and sales performance in the electrophysiology manufacturing market during the class period from July 25, 2024, to October 22, 2025 [3]. Group 1: Allegations - The complaint alleges that Integer overstated its competitive position within the growing electrophysiology manufacturing market [3]. - Despite claims of strong visibility into customer demand, Integer was experiencing a sustained deterioration in sales related to two of its electrophysiology devices [3]. - Integer mischaracterized its electrophysiology devices as a long-term growth driver for the Company's cardio & vascular segment [3]. - As a result of these issues, the defendants' positive statements about the Company's business, operations, and prospects were materially false and misleading [3]. Group 2: Class Action Details - Shareholders who purchased shares of ITGR during the specified class period are encouraged to contact the Gross Law Firm regarding possible lead plaintiff appointment [1]. - The deadline for shareholders to register for the class action is February 9, 2026 [4]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive status updates throughout the lifecycle of the case [4].
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Integer Holdings Corporation (ITGR) Shareholders
Globenewswire· 2025-12-26 21:56
Core Viewpoint - A class action securities lawsuit has been filed against Integer Holdings Corporation, alleging securities fraud that affected investors between July 25, 2024, and October 22, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that Integer Holdings materially overstated its competitive position in the electrophysiology manufacturing market [2]. - It is alleged that despite claims of strong customer demand visibility, the company was experiencing a decline in sales for two of its electrophysiology devices [2]. - The company mischaracterized its electrophysiology devices as long-term growth drivers for its cardio & vascular segment, leading to misleading positive statements about its business and prospects [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until February 9, 2026, to request appointment as lead plaintiff, although participation in any recovery does not require serving as lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing significant settlements for shareholders and is recognized as one of the top securities litigation firms in the United States [4].